A Transgenic Model of Visceral Obesity and the Metabolic Syndrome
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
The adverse metabolic consequences of obesity are best predicted by the quantity of visceral fat. Excess glucocorticoids produce visceral obesity and diabetes, but circulating glucocorticoid levels are normal in typical obesity. Glucocorticoids can be produced locally from inactive 11-keto forms through the enzyme 11β hydroxysteroid dehydrogenase type 1 (11β HSD-1). We created transgenic mice overexpressing 11β HSD-1 selectively in adipose tissue to an extent similar to that found in adipose tissue from obese humans. These mice had increased adipose levels of corticosterone and developed visceral obesity that was exaggerated by a high-fat diet. The mice also exhibited pronounced insulin-resistant diabetes, hyperlipidemia, and, surprisingly, hyperphagia despite hyperleptinemia. Increased adipocyte 11β HSD-1 activity may be a common molecular etiology for visceral obesity and the metabolic syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“other health outcomes associated with better quality of life improved, including sleep apnoea136 and mobility137.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [137]
Citations
Cites
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,237
Role of leptin in the neuroendocrine response to fasting
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996) · Nature · doi:10.1038/382250a0 · Cited by 3,117
Self-citationSubcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
Ahima, R. S., & Flier, J. S. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.413 · Cited by 1,428
Self-citationThe Degree of Masculine Differentiation of Obesities
VAGUE, J. (1956) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/4.1.20 · Cited by 1,410
Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver
Abel, E. D., Peroni, O., Kim, J. K., Kim, Y.-B., Boss, O., Hadro, E., Minnemann, T., Shulman, G. I., & Kahn, B. B. (2001) · Nature · doi:10.1038/35055575 · Cited by 1,253
Frühbeck, G., Gómez-Ambrosi, J., Muruzábal, F. J., & Burrell, M. A. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.6.e827 · Cited by 974
Research works printed but not linked: 5
- 10.1210/jcem.86.3.7453 · doi:10.1210/jcem.86.3.7453 · Paper page
- 10.1101/gad.7.7b.1318 · doi:10.1101/gad.7.7b.1318 · Paper page
- Supplementary data are available on Science Online at www.sciencemag.org/cgi/content/full/294/5549/2166/DC1.
- Strack A. M., Bradbury M. J., Dallman M. F., Am. J. Physiol. 268, R183 (1995).
- 10.1210/jcem.83.5.4951 · doi:10.1210/jcem.83.5.4951 · Paper page
Cited by
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
“Mice with transgenic overexpression of 11 HSD1 in adipocytes have normal serum glucocorticoids and HPA axis function but have elevated local glucocorticoid concentrations in adipose tissue (82).”
Self-citationPhysiology and neurobiology of stress and adaptation: central role of the brain
McEwen, B. S. (2007) · Physiological Reviews · doi:10.1152/physrev.00041.2006 · Cited by 5,429
(1998) · PubMed · Cited by 2,737
Pathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander-Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,154
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Yang, Q., Graham, T. E., Mody, N., Preitner, F., Peroni, O. D., Zabolotny, J. M., Kotani, K., Quadro, L., & Kahn, B. B. (2005) · Nature · doi:10.1038/nature03711 · Cited by 2,086
Yki-Järvinen, H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041001 · Cited by 1,830
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743
Adipose Tissue as an Endocrine Organ
Ahima, R. S., & Flier, J. S. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00301-5 · Cited by 1,608
Self-citationOverweight in Children and Adolescents: Pathophysiology, Consequences, Prevention, and Treatment
Daniels, S. R., Arnett, D. K., Eckel, R. H., Gidding, S. S., Hayman, L. L., Kumanyika, S., Robinson, T. N., Scott, B. J., St. Jeor, S., & Williams, C. L. (2005) · Circulation · doi:10.1161/01.cir.0000161369.71722.10 · Cited by 1,550
Developmental Origin of Fat: Tracking Obesity to Its Source
Gesta, S., Tseng, Y.-H., & Kahn, C. R. (2007) · Cell · doi:10.1016/j.cell.2007.10.004 · Cited by 1,508
“For example, transgenic mice overexpressing 11-β hydroxysteroid dehydrogenase in fat have the same level of enzyme in various fat depots but develop only visceral obesity (Masuzaki et al., 2001).”
Obesity and the role of adipose tissue in inflammation and metabolism
Greenberg, A. S., & Obin, M. S. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.461s · Cited by 1,273
“pression, hyperphagia, hyperlipidemia, and hypertension (64).”
Holland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232
“…likely driven by increased activity of 11b-hydroxysteroid dehydrogenase type 1, which converts inactive cortisone into active cortisol—causes insulin resistance in rodents and may contribute to the development of the disease in humans (Kotelevtsev et al., 1997, 1999; Masuzaki et al., 2001, 2003).”
BackgroundGrundy, S. M. (2011) · Atlas of Atherosclerosis and Metabolic Syndrome · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,223
The Human Obesity Gene Map: The 2005 Update
Rankinen, T., Zuberi, A., Chagnon, Y. C., Weisnagel, S. J., Argyropoulos, G., Walts, B., Pérusse, L., & Bouchard, C. (2006) · Obesity · doi:10.1038/oby.2006.71 · Cited by 1,119
“Promoter aP2-specific expression Increased adiposity (426)”
Flier, J. S. (2004) · Cell · doi:10.1016/s0092-8674(03)01081-x · Cited by 1,112
Self-citationAn integrative genomics approach to infer causal associations between gene expression and disease
Schadt, E. E., Lamb, J., Yang, X., Zhu, J., Edwards, S., GuhaThakurta, D., Sieberts, S. K., Monks, S., Reitman, M., Zhang, C., et al. (2005) · Nature Genetics · doi:10.1038/ng1589 · Cited by 1,043
“The association of Hsd11b1 with the OFPM trait was previously established in a transgenic mouse overexpressing Hsd11b1 in adipose tissu”
BackgroundFructose, weight gain, and the insulin resistance syndrome,,
Elliott, S. S., Keim, N. L., Stern, J. S., Teff, K., & Havel, P. J. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.5.911 · Cited by 1,039
“Increased expression of this enzyme, specifically in adipose tissue, was shown recently to induce visceral obesity, insulin-resistant diabetes, and hyperlipidemia in a transgenic mouse model (13).”
Background11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969
“Mice overexpressing 11 -HSD1 under the aP2 promoter have enhanced adipocyte differentiation (as measured by increased fat cell size) as a consequence of increased adipose tissue corticosteroid concentrations (139) (see Section VII.”
Greenland (2000) · doi:10.1161/01.cir.101.1.e16 · Cited by 924
Samuelsson, A.-M., Matthews, P. A., Argenton, M., Christie, M. R., McConnell, J. M., Jansen, E. H. J. M., Piersma, A. H., Ozanne, S. E., Twinn, D. F., Remacle, C., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.101477 · Cited by 923
Laaksonen, D. E., Niskanen, L., Punnonen, K., Nyyssönen, K., Tuomainen, T.-P., Valkonen, V.-P., Salonen, R., & Salonen, J. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1036 · Cited by 920
The endocrine function of adipose tissue: an update
Ronti, T., Lupattelli, G., & Mannarino, E. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02474.x · Cited by 902
11β-hydroxysteroid dehydrogenases: Intracellular gate-keepers of tissue glucocorticoid action
Chapman, K., Holmes, M., & Seckl, J. (2013) · Physiological Reviews · doi:10.1152/physrev.00020.2012 · Cited by 887
Self-citationCohen, P., Levy, J. D., Zhang, Y., Frontini, A., Kolodin, D. P., Svensson, K. J., Lo, J. C., Zeng, X., Ye, L., Khandekar, M. J., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.021 · Cited by 876
“Transgenic mice overexpressing 11-bHSD-1 in adipose tissue develop VISC obesity along with insulin resistance, diabetes, and hyperlipidemia (Masuzaki et al., 2001).”
BackgroundResultTanaka, T., Yamamoto, J., Iwasaki, S., Asaba, H., Hamura, H., Ikeda, Y., Watanabe, M., Magoori, K., Ioka, R. X., Tachibana, K., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306981100 · Cited by 832
Mechanisms of obesity-associated insulin resistance: many choices on the menu
Qatanani, M., & Lazar, M. A. (2007) · Genes & Development · doi:10.1101/gad.1550907 · Cited by 778
“Transgenic overexpression of 11 HSD1 selectively in mouse adipose tissue produces a syndrome of visceral obesity, insulin resistance, and diabetes (Masuzaki et al. 2001), suggesting that increases in endogenous 11 -HSD1 that have been observed in adipose tissue of obese humans and rodents (Livingstone et al.”
BackgroundSteinberger, J., Daniels, S. R., Eckel, R. H., Hayman, L., Lustig, R. H., McCrindle, B., & Mietus-Snyder, M. L. (2009) · Circulation · doi:10.1161/circulationaha.108.191394 · Cited by 712
Adipose Tissue as an Endocrine Organ
Ahima, R. S. (2006) · Obesity · doi:10.1038/oby.2006.317 · Cited by 640
Short-chain dehydrogenases/reductases (SDR): the 2002 update
Oppermann, U., Filling, C., Hult, M., Shafqat, N., Wu, X., Lindh, M., Shafqat, J., Nordling, E., Kallberg, Y., Persson, B., et al. (2003) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00164-3 · Cited by 633
The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis
Anagnostis, P., Athyros, V. G., Tziomalos, K., Karagiannis, A., & Mikhailidis, D. P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0370 · Cited by 613
“Overactivity of 11 -HSD1 is associated with enhanced expression of GRa in adipose tissue and increased intracellular conversion of cortisone to cortisol (121, 122).”
BackgroundCalcium and Dairy Acceleration of Weight and Fat Loss during Energy Restriction in Obese Adults
Zemel, M. B., Thompson, W., Milstead, A., Morris, K., & Campbell, P. (2004) · Obesity Research · doi:10.1038/oby.2004.67 · Cited by 601
Reversal of obesity by targeted ablation of adipose tissue
Kolonin, M. G., Saha, P. K., Chan, L., Pasqualini, R., & Arap, W. (2004) · Nature Medicine · doi:10.1038/nm1048 · Cited by 601
“Obesity is associated with increased risk for diabetes mellitus, cancer and heart disease, and it often causes shortening of human lif”
BackgroundHolland, W. L., & Summers, S. A. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0025 · Cited by 595
“Transgenic overexpression of 11HSD1 in adipose tissue causes obesity, hypertension, and insulin resistance (62, 63), and knockout mice lacking the enzyme are protected from diabetes (64).”
BackgroundSignalling role of adipose tissue: adipokines and inflammation in obesity
Trayhurn, P., & Wood, I. S. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331078 · Cited by 588
How Obesity Causes Diabetes: Not a Tall Tale
Lazar, M. A. (2005) · Science · doi:10.1126/science.1104342 · Cited by 568
The effects of glucocorticoids on adipose tissue lipid metabolism
Peckett, A. J., Wright, D. C., & Riddell, M. C. (2011) · Metabolism · doi:10.1016/j.metabol.2011.06.012 · Cited by 548
“It has also been reported that both 11β-HSD1 [47] and GR levels [2,48] are higher in visceral compared with subcutaneous adipose depots, with visceral adipocytes showing a greater ability to bind GCs [49].”
BackgroundInfluentialLee, J. H., Chan, J. L., Yiannakouris, N., Kontogianni, M., Estrada, E., Seip, R., Orlova, C., & Mantzoros, C. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030519 · Cited by 548
Regulation of adipocytokines and insulin resistance
Fasshauer, M., & Paschke, R. (2003) · Diabetologia · doi:10.1007/s00125-003-1228-z · Cited by 545
“In addition, transgenic over-expression of 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) in fat tissue, which significantly increases local glucocorticoid concentrations, decreases adiponectin mRNA expression in vivo [107].”
BackgroundThe metabolic syndrome and adipocytokines
Matsuzawa, Y. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.028 · Cited by 542
Glucocorticoids, metabolism and metabolic diseases
Vegiopoulos, A., & Herzig, S. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.05.015 · Cited by 535
“This is particularly remarkable since the transgene is expressed in all different types of fat depots [194].”
BackgroundThe gut and energy balance: visceral allies in the obesity wars
Badman, M. K., & Flier, J. S. (2005) · Science · doi:10.1126/science.1109951 · Cited by 532
Self-citationMorton, N. M., Paterson, J. M., Masuzaki, H., Holmes, M. C., Staels, B., Fievet, C., Walker, B. R., Flier, J. S., Mullins, J. J., & Seckl, J. R. (2004) · Diabetes · doi:10.2337/diabetes.53.4.931 · Cited by 512
“An emerging concept suggests that amplification of glucocorticoid action within adipose tissue by the intracellular enzyme 11 -hydroxysteroid dehydrogenase type 1 (11 -HSD-1) plays a key role in the development of central obesity in humans (3–5) and rodents (6,7), thus providing a molecular basis for the phenotypic si…”
BackgroundInfluentialSelf-citationEndocrine and signalling role of adipose tissue: new perspectives on fat
Trayhurn, P. (2005) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2005.01468.x · Cited by 502
“In addition, certain steroid hormone conversions can take place within white adipocytes, such as the activation of inert 11-dehydrocorticosterone (cortisone in humans) into active corticosterone (cortisol) catalysed by the enzyme 11b-hydroxysteroid dehydrogenase type 1 (Masuzaki et al. 2001).”
MethodInteractions between sleep, stress, and metabolism: From physiological to pathological conditions
Hirotsu, C., Tufik, S., & Andersen, M. L. (2015) · Sleep Science · doi:10.1016/j.slsci.2015.09.002 · Cited by 495
“[115] Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, et al.”
Long-Lasting Effects of Undernutrition
Martins, V. J. B., Toledo Florêncio, T. M. M., Grillo, L. P., Do Carmo P. Franco, M., Martins, P. A., Clemente, A. P. G., Santos, C. D. L., Vieira, M. D. F. A., & Sawaya, A. L. (2011) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph8061817 · Cited by 487
“Furthermore, cortisol raises the activity of lipoprotein lipase, increasing the rate of plasma fatty acid uptake [59,60].”
BackgroundObesity and androgens: facts and perspectives
Pasquali, R. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.10.054 · Cited by 469
Peroxisome proliferator-activated receptor γ in diabetes and metabolism
Rangwala, S. M., & Lazar, M. A. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.03.012 · Cited by 450
Gavrila, A., Chan, J. L., Yiannakouris, N., Kontogianni, M., Miller, L. C., Orlova, C., & Mantzoros, C. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030214 · Cited by 441
“It is also possible that local cortisol production by adipose tissue in amounts that do not increase serum cortisol levels (34) may still alter adiponectin expression in visceral fat (21, 22), but this requires further investigation.”
BackgroundVan Raalte, D. H., Ouwens, D. M., & Diamant, M. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.02067.x · Cited by 439
Sex hormones, inflammation and the metabolic syndrome: a population-based study
Laaksonen, D., Niskanen, L., Punnonen, K., Nyyssonen, K., Tuomainen, T., Salonen, R., Rauramaa, R., & Salonen, J. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490601 · Cited by 438
Masuzaki, H., Yamamoto, H., Kenyon, C. J., Elmquist, J. K., Morton, N. M., Paterson, J. M., Shinyama, H., Sharp, M. G. F., Fleming, S., Mullins, J. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17845 · Cited by 434
“84 The Journal of Clinical Investigation | July 2003 | Volume 112 | Number 1 study by Massiera et al. has demonstrated that overexpression of AGT exclusively in adipose tissue in transgenic (Tg) mice results in significant elevation of BP, suggesting a possible pathophysiologic role of adipose AGT in obesity-related h…”
BackgroundMethodInfluentialSelf-citationGlucocorticoid regulation of the circadian clock modulates glucose homeostasis
So, A. Y.-L., Bernal, T. U., Pillsbury, M. L., Yamamoto, K. R., & Feldman, B. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909733106 · Cited by 431
“Dysregulation of glucocorticoid signaling has been implicated in the pathogenesis of diseases, such as metabolic syndrome and diabetes (2, 3).”
BackgroundPaterson, J. M., Morton, N. M., Fievet, C., Kenyon, C. J., Holmes, M. C., Staels, B., Seckl, J. R., & Mullins, J. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305524101 · Cited by 431
Self-citationPathogenesis of steatohepatitis
Day, C. P. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0333 · Cited by 431
Savage, D. B., Tan, G. D., Acerini, C. L., Jebb, S. A., Agostini, M., Gurnell, M., Williams, R. L., Umpleby, A. M., Thomas, E. L., Bell, J. D., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.4.910 · Cited by 430
“(42) recently described a murine model of syndrome X in mice selectively overexpressing 11- -hydroxysteroid dehydrogenase 1 (HSD-1) in adipocytes.”
BackgroundIncollingo Rodriguez, A. C., Epel, E. S., White, M. L., Standen, E. C., Seckl, J. R., & Tomiyama, A. J. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.08.014 · Cited by 422
“…visceral obesity, the implication is that intra-adipose glucocorticoid levels are key drivers of obesity and metabolic disease over and above blood levels (Masuzaki et al., 2001), which of course contributes to, but is not the sole determinant of intraadipose glucocorticoid concentrations.”
BackgroundSelf-citationThe adipose-tissue renin–angiotensin–aldosterone system: role in the metabolic syndrome?
Engeli, S., Schling, P., Gorzelniak, K., Boschmann, M., Janke, J., Ailhaud, G., Teboul, M., Massiéra, F., & Sharma, A. M. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00311-4 · Cited by 415
“Both AGT gene expression (Masuzaki et al., 2001) and blood pressure (Jeffrey Flier, personal communication) were increased compared to WT mice.”
ResultMinireview: Glucocorticoids—Food Intake, Abdominal Obesity, and Wealthy Nations in 2004
Dallman, M. F., la Fleur, S. E., Pecoraro, N. C., Gomez, F., Houshyar, H., & Akana, S. F. (2004) · Endocrinology · doi:10.1210/en.2004-0037 · Cited by 415
Stress and Obesity: Are There More Susceptible Individuals?
van der Valk, E. S., Savas, M., & van Rossum, E. F. C. (2018) · Current Obesity Reports · doi:10.1007/s13679-018-0306-y · Cited by 402
Lipid overload and overflow: metabolic trauma and the metabolic syndrome
UNGER, R. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2003.09.008 · Cited by 401
An immune origin of type 2 diabetes?
Kolb, H., & Mandrup-Poulsen, T. (2005) · Diabetologia · doi:10.1007/s00125-005-1764-9 · Cited by 394
Mechanisms of Glucocorticoid-Induced Insulin Resistance
Geer, E. B., Islam, J., & Buettner, C. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.10.005 · Cited by 392
PAI-1 and the Metabolic Syndrome: Links, Causes, and Consequences
Alessi, M.-C., & Juhan-Vague, I. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000242905.41404.68 · Cited by 390
Role of premature leptin surge in obesity resulting from intrauterine undernutrition
Yura, S., Itoh, H., Sagawa, N., Yamamoto, H., Masuzaki, H., Nakao, K., Kawamura, M., Takemura, M., Kakui, K., Ogawa, Y., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.005 · Cited by 387
“Obesity is often associated with insulin resistance, dyslipidemia, and hypertension, thus a concept of metabolic syndrome has been proposed (Masuzaki et al., 2001; Wajchenberg, 2000).”
BackgroundSelf-citationRask, E., Walker, B. R., Söderberg, S., Livingstone, D. E. W., Eliasson, M., Johnson, O., Andrew, R., & Olsson, T. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8661 · Cited by 386
Macfarlane, D. P., Forbes, S., & Walker, B. R. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0054 · Cited by 385
“…of 11b-HSD1 in mice are associated with a host of alterations in fatty acid metabolism. aP2 11b-HSD1 overexpressors have a threefold increase in plasma NEFA (as well as corticosterone) levels in the portal vein, with a less pronounced elevation in the systemic circulation (Masuzaki et al. 2001).”
BackgroundMinireview: From Anorexia to Obesity—The Yin and Yang of Body Weight Control
Zigman, J. M., & Elmquist, J. K. (2003) · Endocrinology · doi:10.1210/en.2003-0241 · Cited by 381
Lee, M.-J., Pramyothin, P., Karastergiou, K., & Fried, S. K. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.029 · Cited by 380
“In mouse models, overexpression of 11-beta hydroxysteroid dehydrogenase 1 (HSD1) using an adipose-specific promoter (aP2) that produces high local concentration of corticosterone within adipose tissue results in the preferential expansion of mesenteric (visceral) fat due to adipocyte hypertrophy [72].”
Background11β-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action
Draper, N., & Stewart, P. M. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06019 · Cited by 375
“The transgenic mice were also markedly insulin resistant and glucose intolerant (Masuzaki et al. 2001).”
BackgroundThe current biology of resistin
Steppan, C. M., & Lazar, M. A. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01306.x · Cited by 373
Hermanowski-Vosatka, A., Balkovec, J. M., Cheng, K., Chen, H. Y., Hernandez, M., Koo, G. C., Le Grand, C. B., Li, Z., Metzger, J. M., Mundt, S. S., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050119 · Cited by 364
A Cluster of Metabolic Defects Caused by Mutation in a Mitochondrial tRNA
Wilson, F. H., Hariri, A., Farhi, A., Zhao, H., Petersen, K. F., Toka, H. R., Nelson-Williams, C., Raja, K. M., Kashgarian, M., Shulman, G. I., et al. (2004) · Science · doi:10.1126/science.1102521 · Cited by 359
Stress and obesity: the role of the hypothalamic–pituitary–adrenal axis in metabolic disease
Bose, M., Oliván, B., & Laferrère, B. (2009) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32832fa137 · Cited by 358
Relationships between Rodent White Adipose Fat Pads and Human White Adipose Fat Depots
Chusyd, D. E., Wang, D., Huffman, D. M., & Nagy, T. R. (2016) · Frontiers in Nutrition · doi:10.3389/fnut.2016.00010 · Cited by 357
“Interestingly, Masuzaki and colleagues (144) created a mouse model overexpressing 11β HSD-1 selectively in adipose tissue that reflected 11β HSD-1 levels observed in adipose tissue from obese humans, who are reported to have increased 11β HSD-1 activity.”
BackgroundMetabolic-cognitive syndrome: A cross-talk between metabolic syndrome and Alzheimer's disease
Frisardi, V., Solfrizzi, V., Seripa, D., Capurso, C., Santamato, A., Sancarlo, D., Vendemiale, G., Pilotto, A., & Panza, F. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.04.007 · Cited by 357
Dairy augmentation of total and central fat loss in obese subjects
Zemel, M. B., Richards, J., Mathis, S., Milstead, A., Gebhardt, L., & Silva, E. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802880 · Cited by 356
“Control” laboratory rodents are metabolically morbid: Why it matters
Martin, B., Ji, S., Maudsley, S., & Mattson, M. P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912955107 · Cited by 354
“Protection from dietinduced obesity and insulin resistance was found in mice lacking 11β-HSD1 (36), whereas mice with adipose tissue-specific overexpression of 11β-HSD1 developed an obese phenotype when fed a high calorie diet (37).”
BackgroundZimmermann, U., Kraus, T., Himmerich, H., Schuld, A., & Pollmächer, T. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00018-9 · Cited by 347
“Recently, a transgenic mouse model of visceral obesity has been proposed to mirror the metabolic syndrome (Masuzaki et al., 2001).”
BackgroundThe developmental origins of adipose tissue
Berry, D. C., Stenesen, D., Zeve, D., & Graff, J. M. (2013) · Development · doi:10.1242/dev.080549 · Cited by 343
“Omental fat, part of the visceral compartment, expresses increased levels of the insulin receptor, 11β hydroxysteroid dehydrogenase (11β HSD) and interleukin 6 (IL6) (Gesta et al., 2007; Masuzaki et al., 2001).”
Backgroundde Kloet, E. R. (2003) · PubMed · Cited by 338
Pivotal role of the mineralocorticoid receptor in corticosteroid‐induced adipogenesis
Caprio, M., Fève, B., Claës, A., Viengchareun, S., Lombès, M., & Zennaro, M.-C. (2007) · The FASEB Journal · doi:10.1096/fj.06-7970com · Cited by 337
“In vivo, convincing evidence exists for a major role of glucocorticoids on adipose differentiation, as elegantly demonstrated in transgenic animal models (2).”
BackgroundThe Hypothalamic‐Pituitary‐Adrenal Axis Activity in Obesity and the Metabolic Syndrome
PASQUALI, R., VICENNATI, V., CACCIARI, M., & PAGOTTO, U. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.009 · Cited by 332
FABP4 Attenuates PPARγ and Adipogenesis and Is Inversely Correlated With PPARγ in Adipose Tissues
Garin-Shkolnik, T., Rudich, A., Hotamisligil, G. S., & Rubinstein, M. (2014) · Diabetes · doi:10.2337/db13-0436 · Cited by 332
“4 than SAT is the key factor inducing the metabolic syndrome, also serving as a source of inflammatory and stress-promoting factors (8; 29-31).”
BackgroundThe Human Obesity Gene Map: The 2004 Update
Pérusse, L., Rankinen, T., Zuberi, A., Chagnon, Y. C., Weisnagel, S. J., Argyropoulos, G., Walts, B., Snyder, E. E., & Bouchard, C. (2005) · Obesity Research · doi:10.1038/oby.2005.50 · Cited by 330
Chemistry and Biochemistry of Type 2 Diabetes
Ross, S. A., Gulve, E. A., & Wang, M. (2004) · Chemical Reviews · doi:10.1021/cr0204653 · Cited by 323
The Human Obesity Gene Map: The 2003 Update
Snyder, E. E., Walts, B., Pérusse, L., Chagnon, Y. C., Weisnagel, S. J., Rankinen, T., & Bouchard, C. (2004) · Obesity Research · doi:10.1038/oby.2004.47 · Cited by 318
Rosenstock, J., Banarer, S., Fonseca, V. A., Inzucchi, S. E., Sun, W., Yao, W., Hollis, G., Flores, R., Levy, R., Williams, W. V., et al. (2010) · Diabetes Care · doi:10.2337/dc09-2315 · Cited by 316
“tract infection 3 (6) 3 (6) 2 (4) 2 (4) 2 (4) 1 (2)”
BackgroundInfluentialSelf-citationEffects of Calcium and Dairy on Body Composition and Weight Loss in African‐American Adults
Zemel, M. B., Richards, J., Milstead, A., & Campbell, P. (2005) · Obesity Research · doi:10.1038/oby.2005.144 · Cited by 314
Jones, H. N., Woollett, L. A., Barbour, N., Prasad, P. D., Powell, T. L., & Jansson, T. (2009) · The FASEB Journal · doi:10.1096/fj.08-116889 · Cited by 310
“Mouse models with moderate to pronounced obesity have been developed and include leptin (34) and leptin receptor (35, 36) knockouts and those with adipose tissue-specific overexpression of 11 -hydroxysteroid dehydrogenase type 1 (37).”
BackgroundAndrogens and body fat distribution
Blouin, K., Boivin, A., & Tchernof, A. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.09.001 · Cited by 309
What is metabolic syndrome, and why are children getting it?
Weiss, R., Bremer, A. A., & Lustig, R. H. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12030 · Cited by 307
FATP1 Is an Insulin-Sensitive Fatty Acid Transporter Involved in Diet-Induced Obesity
Wu, Q., Ortegon, A. M., Tsang, B., Doege, H., Feingold, K. R., & Stahl, A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.9.3455-3467.2006 · Cited by 296
Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks
Yang, X., Deignan, J. L., Qi, H., Zhu, J., Qian, S., Zhong, J., Torosyan, G., Majid, S., Falkard, B., Kleinhanz, R. R., et al. (2009) · Nature Genetics · doi:10.1038/ng.325 · Cited by 288
“Therefore, it was not surprising to find C3AR1 , LACTB and LPL as well as the previously characterized HSD11B1 (ref”
BackgroundDraper, N., Walker, E. A., Bujalska, I. J., Tomlinson, J. W., Chalder, S. M., Arlt, W., Lavery, G. G., Bedendo, O., Ray, D. W., Laing, I., et al. (2003) · Nature Genetics · doi:10.1038/ng1214 · Cited by 285
“) and adipose tissue (increased adipocyte differentiation and visceral obesit”
BackgroundTranscriptional networks and chromatin remodeling controlling adipogenesis
Siersbæk, R., Nielsen, R., & Mandrup, S. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.10.001 · Cited by 285
Sarzani, R., Salvi, F., Dessì-Fulgheri, P., & Rappelli, A. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f624a0 · Cited by 284
Adipogenesis: cellular and molecular aspects
Fève, B. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.07.007 · Cited by 281
Doege, H., Baillie, R. A., Ortegon, A. M., Tsang, B., Wu, Q., Punreddy, S., Hirsch, D., Watson, N., Gimeno, R. E., & Stahl, A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.006 · Cited by 279
Metadata
- Authors
- Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- University of Edinburgh (GB)
- Corresponding author
- Flier, Jeffrey S.
- Venue
- Science
- Published
- 2001-12-07
- Volume
- 294
- Issue
- 5549
- Pages
- 2166-2170
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2117268230
- Cited by
- 1,766
- References
- 34
- Citations by year
- 2026: 9 · 2025: 21 · 2024: 30 · 2023: 19 · 2022: 23 · 2021: 44 · 2020: 34 · 2019: 39 · 2018: 54 · 2017: 52 · 2016: 63 · 2015: 74 · 2014: 72 · 2013: 106 · 2012: 98
- FWCI
- 71.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- visceral obesity, metabolic syndrome, 11β-hydroxysteroid dehydrogenase type 1, glucocorticoids, corticosterone, adipose tissue, transgenic mice, insulin resistance, diabetes mellitus, hyperlipidemia, hyperphagia, leptin, high-fat diet
- MeSH terms
- Abdomen, Adipose Tissue, Animals, Body Composition, Corticosterone, Dietary Fats, Disease Models, Animal, Eating, Humans, Hydroxysteroid Dehydrogenases, Hyperglycemia, Hyperinsulinism, Insulin Resistance, Lipids, Lipoprotein Lipase, Male, Mice, Transgenic, Obesity, Receptors, Glucocorticoid, Viscera, Weight Gain, Adipocytes, Gene Targeting, Leptin, Metabolic Syndrome, 11-beta-Hydroxysteroid Dehydrogenase Type 1, Cell Size, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.